| | | | | | | | | | |
|
| |
|
| Dockets Entered
On August 17, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0036L
|
| OTC Laxative
|
|
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
|
|
| 2000D-1598
|
| Voluntary Labeling for Bioengineered Foods
|
|
|
|
|
| 2001N-0548
|
| Guidelines for Voluntary Nutrition Labeling of Raw Fruits
|
|
|
|
|
| 2005N-0500
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Requirements for Collection of Data Relating to the Prevention of Medical Gas Mix-ups at Health Care Facilities - Survey
|
|
|
|
|
|
|
|
|
| 2006D-0301
|
| Guidance for Industry: Animal Drug User Fees; Fees Exceed Costs Waivers and Reductions
|
|
|
|
|
| 2006E-0252
|
| Patent Extension Application for LEVEMIR insulin detemir (rDNA origin) injection, U.S. Patent No. 5,750,497
|
|
|
|
|
| 2006N-0166
|
| Agency Emergency Processing Under OMB Review; MedWatch - The FDA Safety Information and Adverse Event Reporting Program; Proposal to Survey MedWatch Partners organizations
|
|
|
|
|
| 2006N-0312
|
| Preparation for International Conference on Harmonization Meetings in Chicago, Illinois; Public Meeting
|
|
|
|
|
| 2006P-0077
|
| Refrain from lifting the administrative stay for amlodipine maleate tablets (NDA 21-435) until after September 25, 2007.
|
|
|
|
|
| 2006P-0151
|
| Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
|
|
|
|
|
| 2006P-0334
|
| Reclassification Petition fo Bone Heterografts
|
|
|
|
|
| 1978N-0036L
|
| OTC Laxative
|
|
|
|
|
| C 216
|
| C.B. Fleet Co., Inc.
|
| Vol #:
|
| 138
|
|
| |
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
|
|
| RPT 19
|
| William Beaumont Hospital
|
| Vol #:
|
| 54
|
|
|
|
|
| 2000D-1598
|
| Voluntary Labeling for Bioengineered Foods
|
|
|
|
|
| ANS 1
|
| FDA/CFSAN to Z Karpukhina
|
| Vol #:
|
| 580
|
|
|
|
|
| C 10015
|
| Z Karpukhina
|
| Vol #:
|
| 580
|
|
|
|
|
| 2001N-0548
|
| Guidelines for Voluntary Nutrition Labeling of Raw Fruits
|
|
|
|
|
| NCR 2
|
| FDA
|
| Vol #:
|
| 5
|
|
|
|
|
| 2005N-0500
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Requirements for Collection of Data Relating to the Prevention of Medical Gas Mix-ups at Health Care Facilities - Survey
|
|
|
|
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SS 1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006D-0301
|
| Guidance for Industry: Animal Drug User Fees; Fees Exceed Costs Waivers and Reductions
|
|
|
|
|
| GDL 1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006E-0252
|
| Patent Extension Application for LEVEMIR insulin detemir (rDNA origin) injection, U.S. Patent No. 5,750,497
|
|
|
|
|
| LET 2
|
| FDA/CDER to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
| |
|
| 2006N-0166
|
| Agency Emergency Processing Under OMB Review; MedWatch - The FDA Safety Information and Adverse Event Reporting Program; Proposal to Survey MedWatch Partners
|
|
| | | | | | | | |
|
| |
|
| organizations
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SS 1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
| |
|
| 2006N-0312
|
| Preparation for International Conference on Harmonization Meetings in Chicago, Illinois; Public Meeting
|
|
|
|
|
| NM 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0077
|
| Refrain from lifting the administrative stay for amlodipine maleate tablets (NDA 21-435) until after September 25, 2007.
|
|
|
|
|
| LET 1
|
| FDA/CDER to Covington & Burling
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0151
|
| Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
|
|
|
|
|
| C 3
|
| Women's Bioethics Project
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0334
|
| Reclassification Petition fo Bone Heterografts
|
|
|
|
|
| ACK 1
|
| FDA/DDM to Regeneration Technologies, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| CCP 1
|
| Regeneration Technologies, Inc.
|
| Vol #:
|
| 1
|
|
